{"denoms":[{"counts":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"39"},{"groupId":"BG003","value":"124"}],"units":"Participants"}],"groups":[{"description":"Allogeneic Stem Cell Transplant: Fludarabine+Melphalan+Bortezomib followed by Allogeneic Rescue.","id":"BG000","title":"A: Allogeneic Stem Cell Transplant"},{"description":"Autologous Stem Cell Transplant: Melphalan+Bortezomib followed by Autologous Rescue.","id":"BG001","title":"B: Autologous Stem Cell Transplant"},{"description":"Group B Expansion on Bortezomib Maintenance: Autologous Only.","id":"BG002","title":"BE: Group B Expansion"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"32","upperLimit":"76","value":"53.5"},{"groupId":"BG001","lowerLimit":"31","upperLimit":"79","value":"62"},{"groupId":"BG002","lowerLimit":"39","upperLimit":"78","value":"62"},{"groupId":"BG003","lowerLimit":"31","upperLimit":"79","value":"60"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"19"},{"groupId":"BG003","value":"62"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"20"},{"groupId":"BG003","value":"62"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"19"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"29"},{"groupId":"BG003","value":"104"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"11"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"38"},{"groupId":"BG002","value":"32"},{"groupId":"BG003","value":"102"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"8"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"39"},{"groupId":"BG003","value":"124"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}],"populationDescription":"Baseline: All participants enrolled on study. Adverse Events: All participants who received study treatment. Outcome Measures: All participants evaluable at time of analysis."}